Introduction
Hypertension, commonly referred to as high blood pressure, significantly contributes to cardiovascular diseases across the globe. In 2023, the European Society of Hypertension (ESH) published updated guidelines aimed at improving the management of arterial hypertension. These guidelines present healthcare providers with the most current evidence-based recommendations for superior patient care.
Key Updates in Hypertension Management
Blood Pressure Classification and Targets
- Classification: According to the ESH 2023 guidelines, hypertension continues to be defined as a systolic blood pressure (SBP) of 140 mmHg or higher and/or a diastolic blood pressure (DBP) of 90 mmHg or more.
- Treatment Targets: For the majority of adults, the recommended targets are an SBP below 130 mmHg and a DBP below 80 mmHg. However, for individuals aged 80 years and above, treatment may start when the SBP reaches 160 mmHg, with targets being considered between 140 and 160 mmHg.
- Weight Management: A weight loss of at least 5% of body mass is suggested to help prevent or treat elevated blood pressure.
- Dietary Adjustments: It is advisable to follow a heart-healthy dietary pattern such as the DASH diet and to limit sodium intake to less than 2,300 mg per day, ideally aiming for less than 1,500 mg per day.
- Physical Activity: Regular engagement in physical exercise plays a vital role in controlling blood pressure levels.
- First-Line Medications: The primary options recommended are angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), long-acting dihydropyridine calcium channel blockers, and thiazide-type diuretics.
- Combination Therapy: For individuals diagnosed with stage 2 hypertension (SBP ≥140 mmHg and/or DBP ≥90 mmHg), it is advisable to initiate treatment using two different medications. Preferred combinations include an ACEi/ARB paired with a calcium channel blocker or an ACEi/ARB combined with a thiazide-like diuretic.
- Renal Denervation: The FDA approved the renal denervation procedure in late 2023 specifically for patients with resistant hypertension. This innovative approach involves employing ultrasound or radiofrequency energy to interfere with overactive renal nerves, resulting in an average decrease of 8–10 mmHg in blood pressure.
- Elderly Patients: For elderly individuals aged 80 and above, it may be appropriate to start treatment at an SBP of 160 mmHg and to consider treatment goals within the 140–160 mmHg range.
- Comorbidities: Carefully managing other health conditions, such as diabetes, chronic kidney disease, and obstructive sleep apnea, is a key aspect of comprehensive hypertension care.
- Blood Pressure Targets: Aim for an SBP below 130 mmHg and a DBP below 80 mmHg in most adults; for those aged 80 and older, consider initiating treatment at an SBP of 160 mmHg.
- Lifestyle Modifications: A weight loss of at least 5% and a reduction in dietary sodium are recommended methods to address hypertension.
- Pharmacological Treatment: Initiate combination therapy utilizing ACEi/ARB with a calcium channel blocker or thiazide-like diuretic for those with stage 2 hypertension.
- European Society of Hypertension, 2023 Guidelines for the Management of Arterial Hypertension. ESH Guidelines
- American College of Cardiology, 2025 High Blood Pressure Guideline Emphasizes Prevention, Early Treatment to Reduce CVD Risk. ACC Guidelines
- Associated Press, Keeping Blood Pressure Under Control Is Critical. There’s a New Option for Tough Cases. AP News
- Astra, Hypertension Management 2024–2025: Guideline Updates and Therapeutic Sequencing. Astra Article
- Guideline Central, 2025 ACC/AHA Guidelines for Management of High Blood Pressure in Adults – Guideline Summary. Guideline Central
Lifestyle Modifications
Research suggests that adopting non-pharmacological strategies is crucial for effective hypertension management. These strategies include:
Pharmacological Treatment
Effective pharmacological treatments are essential for controlling blood pressure. Recommendations for initiating and adjusting therapy include:
Special Considerations
Conclusion
The 2023 ESH guidelines establish a robust framework for managing arterial hypertension, positioning early intervention, personalized treatment strategies, and the combination of lifestyle changes and pharmacological treatments as core elements for successful management. It is essential for healthcare professionals to remain informed about these guidelines to enhance patient care outcomes.